Skip to content
Back to all use casesCommercial

Developing Value based pricing through RWE

The problem

Problem statement

Pricing teams want to build value-based pricing models grounded in real-world evidence (RWE), but connecting RWE data to defensible pricing scenarios is a slow, largely manual analytical exercise. Build a tool that turns real-world evidence into structured value-based pricing scenarios, helping pricing teams build faster, better-supported pricing strategies.

One-pager

ValueLens

REAL-WORLD EVIDENCE FOR VALUE-BASED PRICING

Prototype One-Pager | For Raj's review

01 WHAT THE PROTOTYPE IS ABOUT

ValueLens

ValueLens is a working prototype of a data-driven platform that turns real-world evidence (RWE) into a defensible price for a therapy in the US market. It connects patient-level evidence (cohorts, outcomes and costs) to the economic arguments payers demand: ICER, QALYs, budget impact and net monetary benefit, culminating in simulated price points and outcomes-based contracts.

02 KEY PROBLEM IT ADDRESSES

TODAY · WITH VALUELENS

7

integrated modules

from data to contract

14

outcomes-based contracts

modelled in the prototype

Weeks to Minutes

value dossiers from live cohorts

TODAY

Value story assembled manually from disconnected sources, spreadsheets and one-off analyses: slow, hard to defend, poorly linked to payer reimbursement.

WITH VALUELENS

One evidence-backed workspace where pricing decisions are driven by real-world data rather than assumptions.

03 KEY FEATURES

FROM EVIDENCE TO PRICE

01 Data Sources

Ingest and profile real-world data feeds (claims, EHR, registry) with quality and readiness checks.

02 Cohort Builder

Define patient cohorts by indication, line of therapy and matching (PSM), with patient counts and match status.

03 Outcomes Engine

Compute ICER, QALYs gained, budget impact (BIM) and net monetary benefit (NMB) from cohort outcomes.

04 Value Calculator

Model the value story (comparator, effectiveness and cost deltas) behind the price.

05 Pricing Simulator

Simulate price points against willingness-to-pay thresholds and see ICER and NMB react instantly.

06 Contracting

Design outcomes-based agreements (OBAs) and track 14 contracts in market.

07 Reports

Export board-ready value dossiers for payer and internal review.

THE PAYER LANGUAGE

ICER QALY BIM NMB

Cohort outcomes to price and contract

THE EVIDENCE-TO-PRICE FLOW

Real-world data

claims, EHR, registry

Cohorts

indication, line, PSM

Outcomes

ICER, QALY, BIM, NMB

Price

simulate vs WTP

Contracts + reports

OBAs, value dossiers

04 EXPECTED BUSINESS IMPACT

Faster price submissions

Value dossiers and ICER analyses that take weeks of analyst effort are generated in minutes from live cohorts.

Stronger payer negotiations

Evidence-backed ICER, QALY and budget-impact views give teams a quantified value story at the negotiation table.

De-risked pricing decisions

The pricing simulator lets leadership test price points against willingness-to-pay thresholds before committing.

New contracting capability

Outcomes-based agreements become operational: 14 contracts modelled show refund/risk exposure transparently.

Portfolio visibility

Executives see cost-vs-QALY trends, ICER frontier and cohort performance across indications on one dashboard.